Tracy Warren
Tracy Warren
Overview
Over fifteen years of experience as an entrepreneur and early stage investor in life science and energy companies with an affinity for institutional based technology commercialization. Serves on boards of for profit and non profit entities across sectors with primary interest in health and life sciences. As an investor Tracy led investments in NuPathe which completed its IPO in 2010 and was subsequently acquired by Teva Pharmaceuticals for over $140 million. She also served as Chairman of BioNano Genomics and on the Board of Micro Interventional Devices.